Clinical Trial Update: HFNC vs. NIV in Acute COPD Exacerbations [NA]

View source ↗

Summary

A completed clinical trial comparing high-flow nasal cannula (HFNC) with noninvasive ventilation (NIV) in acute COPD exacerbations with hypercapnic respiratory …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Hypercapnic Respiratory Failure
• Respiratory Failure

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: COPD Exacerbations, Acute Hypercapnic Respiratory Failure | NA | Status: COMPLETED